MDT

89.59

-0.42%↓

VEEV

282.47

+2.4%↑

A

120.22

-2.5%↓

WBA

11.48

-0.26%↓

HQY

96.31

+1.97%↑

MDT

89.59

-0.42%↓

VEEV

282.47

+2.4%↑

A

120.22

-2.5%↓

WBA

11.48

-0.26%↓

HQY

96.31

+1.97%↑

MDT

89.59

-0.42%↓

VEEV

282.47

+2.4%↑

A

120.22

-2.5%↓

WBA

11.48

-0.26%↓

HQY

96.31

+1.97%↑

MDT

89.59

-0.42%↓

VEEV

282.47

+2.4%↑

A

120.22

-2.5%↓

WBA

11.48

-0.26%↓

HQY

96.31

+1.97%↑

MDT

89.59

-0.42%↓

VEEV

282.47

+2.4%↑

A

120.22

-2.5%↓

WBA

11.48

-0.26%↓

HQY

96.31

+1.97%↑

Search

AcelRx Pharmaceuticals Inc

Aperta

0

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

Massimo

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+532.91% upside

AcelRx Pharmaceuticals Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 lug 2025, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

FCC Approves U.S. Cellular Sale to T-Mobile

11 lug 2025, 17:28 UTC

I principali Market Mover

SharpLink Gaming Gains on Ethereum Purchase

11 lug 2025, 16:57 UTC

Utili

BASF Cuts Outlook on Global Economy Uncertainty

13 lug 2025, 23:54 UTC

Discorsi di Mercato

Oil Edges Higher Amid Supply Disruption Worries -- Market Talk

13 lug 2025, 23:49 UTC

Discorsi di Mercato

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

13 lug 2025, 23:49 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

13 lug 2025, 23:40 UTC

Discorsi di Mercato

Market Talk Roundup: Latest on U.S. Politics

13 lug 2025, 23:40 UTC

Discorsi di Mercato

Gold Advances Amid Rising Trade Tensions -- Market Talk

13 lug 2025, 23:39 UTC

Discorsi di Mercato

China's Growth Momentum Likely Slowed in 2Q -- Market Talk

13 lug 2025, 23:16 UTC

Utili

China Shenhua Energy 1H 2024 Net Was CNY32.8B>1088.HK

13 lug 2025, 23:16 UTC

Utili

China Shenhua Energy: Drop in Coal Prices Weighed on Results >1088.HK

13 lug 2025, 23:16 UTC

Utili

China Shenhua Energy Sees 1H Net CNY25.6B-Net CNY27.6B >1088.HK

13 lug 2025, 23:13 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

13 lug 2025, 23:13 UTC

Discorsi di Mercato

Ryman Healthcare Could Be Turning a Corner -- Market Talk

13 lug 2025, 11:00 UTC

Acquisizioni, Fusioni, Takeovers

The Private-Equity Maneuver Allowing More Investors to Cash Out -- WSJ

12 lug 2025, 02:24 UTC

Acquisizioni, Fusioni, Takeovers

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

12 lug 2025, 02:05 UTC

Acquisizioni, Fusioni, Takeovers

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

12 lug 2025, 02:05 UTC

Acquisizioni, Fusioni, Takeovers

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

12 lug 2025, 02:05 UTC

Acquisizioni, Fusioni, Takeovers

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

11 lug 2025, 21:45 UTC

Discorsi di Mercato

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 lug 2025, 19:46 UTC

Acquisizioni, Fusioni, Takeovers

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 lug 2025, 19:45 UTC

Discorsi di Mercato

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 lug 2025, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 lug 2025, 18:18 UTC

Discorsi di Mercato

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 lug 2025, 17:35 UTC

Discorsi di Mercato

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 lug 2025, 17:26 UTC

Discorsi di Mercato

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 lug 2025, 16:53 UTC

Discorsi di Mercato

Crude Futures Add to Early Gains -- Market Talk

11 lug 2025, 16:42 UTC

Utili

BASF Cuts Outlook on Global Economic Uncertainty

11 lug 2025, 16:08 UTC

Discorsi di Mercato

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 lug 2025, 16:05 UTC

Utili

BASF Will Publish Half-Year Results on July 30

Confronto tra pari

Modifica del prezzo

AcelRx Pharmaceuticals Inc Previsione

Obiettivo di Prezzo

By TipRanks

532.91% in crescita

Previsioni per 12 mesi

Media 5 USD  532.91%

Alto 5 USD

Basso 5 USD

Basato su 1 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per AcelRx Pharmaceuticals Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

1 ratings

1

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

$